Results 151 to 160 of about 30,157 (233)

Types of Pain in Multiple System Atrophy

Movement Disorders, EarlyView.
Abstract Background Pain affects up to 87% of people with multiple system atrophy (MSA), but it remains unclear which types of pain contribute most to the overall burden. Objective To estimate the frequency of different types of pain in MSA individuals.
Nicole Campese, Mubasher A. Qamar, Maria Alexandra Chiriac, Georg Göbel, Julia Wanschitz, Andreas Schlager, Bianca Caliò, Fabian Leys, Pam Bower, Laura Zamarian, Anette Schrag, Roy Freeman, Horacio Kaufmann, Roberta Granata, Stefan Kiechl, Werner Poewe, Klaus Seppi, Gregor Wenning, K. Ray Chaudhuri, Alessandra Fanciulli   +19 more
wiley   +1 more source

Medicaid Expansion and Retail Pharmacy Availability.

JAMA Health Forum
Kakani P, Lu J, Qato DM, Nicholson S, Schpero WL.   +4 more
europepmc   +1 more source

Transferability of Real World Evidence to Support HTA Recommendations in Lower Income European Countries. [PDF]

Health Sci Rep
Kaló Z, Petrova G, Németh B, Bonča PD, Delnoij D, Bennett A, Tachkov K, Zhang Y, Kreif N, Knies S, Lipska I, Tesar T, Mitkova Z, Ponten J, Viberg A, Paveliu MS, Piniazkho O, Turcu-Stiolica A, Doležal T, Staňák M, Almadiyeva A, Hren R, Vitezić D, Petykó Z, Goettsch W, Manca A.   +25 more
europepmc   +1 more source

Reconsidering Volume‐Based Drug Procurement Policy: The Consequences of Manufacturers' Optimal Production Planning and Breach Strategies

Naval Research Logistics (NRL), EarlyView.
ABSTRACT This paper examines the impacts of Volume‐Based Procurement (VBP) policies on pharmaceutical supply chains, with a focus on the strategic behaviors of manufacturers. VBP aims to reduce costs and stabilize supplies by centralizing procurement through competition based on volumes and prices.
Nani Zhou, Tong Wang, Guohua Wan
wiley   +1 more source

Human and financial consequences of herding in oncology drug development: clinical trials of TIGIT inhibitors. [PDF]

BMJ Oncol
Zhang ES, Osipenko L, Hickman JA.
europepmc   +1 more source

Trends in Use of Obesity Medications and Metabolic and Bariatric Surgery Among All of Us Participants From 2003 to 2023

Obesity, EarlyView.
ABSTRACT Objective This study aimed to evaluate the trends in antiobesity medication (AOM) and metabolic and bariatric surgery (MBS) use relative to the 2013 American Medical Association (AMA) declaration of obesity as a chronic disease and semaglutide approval in 2021 in the United States.
Olajide A. Adekunle, Phuc Le, Christopher Boyer, Hamlet Gasoyan, Dev Yash Gupta, Ha T. Tran, Yihua Yue, Michael B. Rothberg   +7 more
wiley   +1 more source

Pharmacoeconomics Education in Pharmacy Faculties: Status in Türkiye and Other Countries. [PDF]

Turk J Pharm Sci
Kızılay H.
europepmc   +1 more source

Joint TOS/OMA/OAC Expert Guidance Statement on the Pharmacological Management of United States Adults With Overweight or Obesity Using the GRADE Approach

Obesity, EarlyView.
Guidance recommendations by TOS/OMA/OAC for the use of obesity medications to treat obesity and its complications. ABSTRACT Background Obesity affects over 40% of US adults, with severe obesity on the rise. Despite recognition of obesity as a chronic disease, it remains underdiagnosed and undertreated.
Lydia Alexander, Jonathan Q. Purnell, Karlijn Burridge, Marc‐André Cornier, Angela Golden, Deborah Bade Horn, Michelle Look, Joe Nadglowski, Camila Ávila‐Oliver, Francisco Novillo, Ana María Rojas‐Gómez, Brad Hussey, Ximena Ramos Salas   +12 more
wiley   +1 more source

Phlorotannins from Phaeophyceae: Structural Diversity, Multi-Target Bioactivity, Pharmacokinetic Barriers, and Nanodelivery System Innovation. [PDF]

Molecules
Harasym J, Słota P, Pejcz E.
europepmc   +1 more source

Plants, Lichens, Fungi, and Algae Extracts and Derivatives with Antimicrobial Properties for Nutrition and Health. [PDF]

Antibiotics (Basel)
Popovici V, Ozon EA, Arsene AL, Schröder V.   +3 more
europepmc   +1 more source